Re-evaluation of the definition of remission on the 17-item Hamilton Depression Rating Scale based on recovery in health-related quality of life in an observational post-marketing...

by Jitsuki Sawamura, Jun Ishigooka, Katsuji Nishimura
Published 2018-01-01

Dual orexin receptor antagonist (DORA-12) treatment affects the overall levels of Net/maoA mRNA expression in the hippocampus

by Shunpei Moriya, Hitoshi Takahashi, Daiki Masukawa, Makiko Yamada, Jun Ishigooka, Katsuji Nishimura
Published 2021-02-01

Ziprasidone, a second-generation antipsychotic, affects core clock gene mRNA expression in mice

by Shunpei Moriya, Hitoshi Takahashi, Daiki Masukawa, Makiko Yamada, Jun Ishigooka, Katsuji Nishimura
Published 2020-09-01

Lurasidone in the long-term treatment of Japanese patients with bipolar I disorder: a 52 week open label study

by Teruhiko Higuchi, Tadafumi Kato, Mari Miyajima, Kei Watabe, Takahiro Masuda, Katsuhiko Hagi, Jun Ishigooka
Published 2021-08-01

Post-traumatic stress disorder and its risk factors in Japanese patients living with implantable cardioverter defibrillators: A preliminary examination

by Sayaka Kobayashi, MA, Katsuji Nishimura, MD, Tsuyoshi Suzuki, MD, Tsuyoshi Shiga, MD, Jun Ishigooka, MD
Published 2014-04-01

Effect of Quetiapine on Per1, Per2, and Bmal1 Clock Gene Expression in the Mouse Amygdala and Hippocampus

by Shunpei Moriya, Yu Tahara, Hiroyuki Sasaki, Yutaro Hamaguchi, Daisuke Kuriki, Ryosuke Ishikawa, Jun Ishigooka, Shigenobu Shibata
Published 2014-01-01

Conducta de evitación asociada a síntomas depresivos en pacientes con desfibriladores cardioversores implantables

by Kanako Ichikura, Sayaka Kobayashi, Shiho Matsuoka, Tsuyoshi Suzuki, Katsuji Nishimura, Tsuyoshi Shiga, Nobuhisa Hagiwara, Jun Ishigooka, Shin-ichi Suzuki
Published 2017-01-01